Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hyperammonemia
|
8 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.030 | 0.667 | 3 | 2014 | 2019 | ||||
Glomerular Filtration Rate
|
1033 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 5 | 2017 | 2019 | ||||
Chronic Kidney Diseases
|
306 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.800 | 1.000 | 3 | 2010 | 2018 | ||||
Finding of Mean Corpuscular Hemoglobin
|
1206 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 3 | 2016 | 2019 | ||||
High density lipoprotein measurement
|
1440 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.800 | 1.000 | 3 | 2013 | 2019 | ||||
Homocysteine measurement
|
33 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.800 | 1.000 | 3 | 2010 | 2014 | ||||
Creatinine measurement, serum (procedure)
|
243 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 2 | 2017 | 2019 | ||||
Kidney Failure, Chronic
|
425 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 2 | 2018 | 2019 | ||||
Mean Corpuscular Volume (result)
|
549 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 2 | 2016 | 2018 | ||||
Systolic Pressure
|
1931 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 2 | 2018 | 2019 | ||||
Alanine aminotransferase measurement
|
77 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
Albuminuria
|
59 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
Alcohol consumption
|
535 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Amino acids measurement
|
92 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||
Blood urea nitrogen measurement
|
174 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Body Height
|
3972 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Diabetes
|
710 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Diabetes Mellitus
|
824 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Epilepsy
|
339 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
fibrinogen activity
|
63 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||
Fibrinogen assay
|
143 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||
Fibrinogen, CTCAE
|
63 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 1 | 2009 | 2009 | ||||
Glycine measurement
|
68 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Lean body mass
|
211 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
Necrotizing Enterocolitis
|
7 | 0.827 | 0.200 | 2 | 210675783 | missense variant | C/A | snv | 0.30 | 0.33 | 0.010 | 1.000 | 1 | 2016 | 2016 |